Mylan NV, the drugmaker under fire for pricing its EpiPen emergency allergy shots at $600, said it will introduce a generic version in coming weeks that will halve the price.
The generic EpiPen will be identical to the branded product, including device functionality and drug formulation, and cost $300 per two-pack carton, Mylan said in a statement on Monday. The company also plans to continue to sell the branded version.
Mylan has attracted scrutiny for increasing the treatment's price to about $600 for a two-pack from $57 for a single pen in 2007.
"Ensuring access to medicine is absolutely the core of Mylan's mission," Chief Executive Officer Heather Bresch said in the statement.
